🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To assess the efficacy of cenegermin-bkbj (20 mcg/mL) o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-26
Trial ID
NCT06411145
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of 20 µg/ml...
Status
Completed
Location
Loma Linda University Ophthalmology
Start Date
2015-02
Trial ID
NCT02227147
Treatments Being Tested
This is a phase 3, randomized, multicenter, vehicle-controlled, double-mask...
Status
Recruiting
Location
Neuro Eye Orbit Institute
Start Date
2026-07-01
Trial ID
NCT07453888
Treatments Being Tested
The primary objective of this study was to assess the efficacy and safety o...
Status
Completed
Location
Department of Clinical Pharmacology
Start Date
2014-01-20
Trial ID
NCT02101281
Treatments Being Tested
This study is aimed at assessing the safety and the efficacy of two dose re...
Status
Completed
Location
CHU de Dijon - Service ophtalmologie
Start Date
2013-01
Trial ID
NCT01756456
Treatments Being Tested
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
WCCT Global
Start Date
2018-03-30
Trial ID
NCT03836859
Treatments Being Tested
The primary objective of this exploratory study is to assess preliminary ef...
Status
Completed
Location
Univ. G. D'Annunzio-Clinica Oftalmologica-Chieti
Start Date
2017-01-12
Trial ID
NCT03035864
Primary Objectives: * To compare the efficacy of cenegermin vs vehicle in ...
Status
Completed
Location
Lugene Eye Institute - Glendale Office
Start Date
2022-01-27
Trial ID
NCT05136170
Treatments Being Tested
The objective of this study is to assess the efficacy and safety of rhNGF e...
Status
Completed
Location
Global Research Management
Start Date
2019-06-10
Trial ID
NCT03982368
Treatments Being Tested
This is a phase 3, randomized, multicenter, double-masked, parallel group, ...
Status
Recruiting
Location
Azul Vision, INC
Start Date
2026-06-02
Trial ID
NCT07519902
Treatments Being Tested